Reading Time: 2 minutesIntroduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, has become a pivotal treatment option for hypogonadism among American males. This study aims to explore the immunological effects of Aveed, specifically focusing on its potential to trigger allergic reactions over a one-year period. Understanding these effects is crucial for optimizing patient safety and treatment efficacy in clinical practice. Background and Rationale Hypogonadism, characterized by low testosterone levels, can significantly impact the quality of life of American males, affecting energy levels, mood, and sexual function. Aveed offers a long-acting solution that requires fewer injections than traditional testosterone therapies, enhancing patient … Continue reading →